Yew Bio Pharm Annual Income Statement (OTCMKTS:YEWB)

Add to My Stocks
$0.21 $0 (0%) YEWB stock closing price Dec 09, 2016 (Closing)

YEWB stock valuation based on fundamental analysis involves checking and analyzing financial statements and not just the Yew Bio Pharm stock price. The key financial statements of a company are the income statement, the balance sheet and the cash flow statement. The income statement is generated for a specific period of time. The revenue increase of $29.57M for 2015 impacts the YEWB stock. Investors typically check year over year or quarter over quarter revenue growth. 2015 revenue is $29.57M and has increased from $7.72M year on year as is evident when you compare the latest figures in the latest Yew Bio Pharm profit and loss statement with those of the prior corresponding period. (See also:Yew Bio Pharm assets and Yew Bio Pharm free cash flow) Yew Bio Pharm revenue for 2015 is $29.57M. View revenue and profit details for latest and last 10 financial years.

show more
Fiscal year is Jan - Dec. 2015 2014 2013 2012 2011
Yew Bio Pharm Net Sales or Revenues
29.57M7.72M7.43M6.72M5.96M
Cost Of Goods Sold (COGS)22.54M2.13M2.4M1.27M1.12M
Yew Bio Pharm Gross Profit
7.03M5.58M5.03M5.44M4.83M
Research & Development Expense-----
Selling General & Admin Expense1.89M1.3M1.13M3.24M0.78M
Income Before Depreciation Depletion Amortization5.13M4.28M3.89M2.2M4.04M
Depreciation Depletion Amortization-----
Non Operating Income0.16M----0.01M
Interest Expense-----
Yew Bio Pharm Pretax Income
5.3M4.28M3.89M2.2M4.04M
Provision for Income Taxes0.01M----
Minority Interest-----
Investment Gains Losses-----
Other Income-----
Income Before Extraordinaries & Disc Operations5.28M4.28M3.89M2.2M4.04M
Extraordinary Items & Discontinued Operations-----
Yew Bio Pharm Net Income (Profit/Loss)
5.28M4.28M3.89M2.2M4.04M
Average Shares used to compute Diluted EPS52.11M----
Average Shares used to compute Basic EPS52.07M----
Income Before Nonrecurring Items5.29M----
Income from Nonrecurring Items-----
Yew Bio Pharm Earnings Per Share Basic Net
0.10----
Yew Bio Pharm Earnings Per Share Diluted Net
0.10----
EPS Diluted Before Nonrecurring Items0.10----
Preferred Dividends Acc Pd-----
Dividends Common-----
Dividend Per Share Common-----
All figures in USD. M: Millions of USD, B: Billions of USD.
Get Income statement for another ticker

The key things to look for in an income statement while doing Yew Bio Pharm stock analysis are:
  • Topline: A growing topline, as seen from the Yew Bio Pharm revenue chart, as is the case with Yew Bio Pharm indicates a growing business. One needs to compare the QoQ or YoY topline growth of YEWB stock with its peers like MRGO stock and CMCI stock to see if the growth compares well with what can be expected for a company in that industry.
  • Bottom line: This refers to the last line in a profit and loss statement and denotes the net profit or loss for a particular period. The figure currently stands at $5.28M for Yew Bio Pharm for 2015. This figure is arrived at after deducting all operating expenses, interest, and taxes from revenue.
The income statement is also called the profit and loss statement. Apart from the income statement, one can check the Yew Bio Pharm historical stock prices to check how the price has moved with time. .

Yew Bio Pharm Income Statement - Key Financial Ratios

PE ratio (price earnings ratio)
2.1200
PS ratio (
price sales ratio
)
0.1943
Operating margin
7.6
Net profit margin
7.4
Dividend yield
0%